US OptionsDetailed Quotes

PAVM241220P2500

Watchlist
  • 0.00
  • 0.000.00%
15min DelayClose Dec 20 09:30 ET
0.00High0.00Low
Intraday
  • 5D
  • Daily

No Data

News

Comments

    Jaguar8
    Jaguar8
    Dec 11 07:21
    NEWS
    $Lucid Diagnostics (LUCD.US)$ $PAVmed (PAVM.US)$
    Prospective Clinical Utility Study of Lucid Diagnostics' EsoGuard® Esophageal DNA Test Accepted for Peer-Reviewed Publication
    Wednesday, 11th December at 8:01 am
    Study demonstrates outstanding clinical utility including an exceptionally high 85% patient compliance with referral to confirmatory upper endoscopy following EsoGuard esophageal precancer testing
    NEW YORK, Dec. 11, 2024 /PRNewswire/ -- Lucid Diagnostics Inc. (NASDAQ: LUCD) ("Lucid" or...
    Trytosaveabit
    Trytosaveabit
    Dec 11 07:03
    Update
    $PAVmed (PAVM.US)$ Prospective Clinical Utility Study of Lucid Diagnostics' EsoGuard® Esophageal DNA Test Accepted for Peer-Reviewed Publication
    2 MINUTES AGO, 8:01 AM EST
    VIA PR NEWSWIRE
    Study demonstrates outstanding clinical utility including an exceptionally high 85% patient compliance with referral to confirmatory upper endoscopy following EsoGuard esophageal precancer testing
    Trytosaveabit
    Trytosaveabit
    Nov 20 06:58
    Update
    $PAVmed (PAVM.US)$ $Lucid Diagnostics (LUCD.US)$ Lucid Diagnostics Submits Clinical Evidence Package to MolDX Seeking Medicare Coverage for EsoGuard Esophageal DNA Test
    PR Newswire· 2 mins ago
    NEW YORK, Nov. 20, 2024 /PRNewswire/ -- Lucid Diagnostics Inc.(Nasdaq: LUCD) ("Lucid" or the "Company") a commercial-stage, cancer prevention medical diagnostics company and subsidiary of PAVmed Inc. (Nasdaq: PAVM), today announced that it has submitted its complete clinical evidence package for its Eso...
    Jaguar8
    Jaguar8
    Oct 10 06:52
    NEWS
    $PAVmed (PAVM.US)$
    PAVmed Subsidiary, Veris Health, Awarded $1.8 Million NIH Grant to Enhance Cancer Care
    PAVmed's subsidiary, Veris Health, has been awarded a $1.8 million grant from the National Institute on Minority Health and Health Disparities (NIMHD), part of the National Institutes of Health (NIH). The two-year grant will fund research to optimize and validate the Veris Cancer Care Platform for medically underserved cancer patients, in partnership with an academic cancer center.
    The ...
    Trytosaveabit
    Trytosaveabit
    Oct 10 06:51
    News
    $PAVmed (PAVM.US)$ Reuters· just
    PAVmed Subsidiary, Veris Health, Awarded $1.8 Million Nih Grant to Enhance Cancer Care
Read more